Study of ORIC-944 in Patients With Metastatic Prostate Cancer
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Pratik S. Multani, MD
ORIC Pharmaceuticals
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
27 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Sydney Adventist Health
Wahroonga, New South Wales, Australia
Recruiting - Bendigo Health
Bendigo, Victoria, Australia
Recruiting - Peninsula Health
Frankston, Victoria, Australia
Not, yet, recruiting
- Next Oncology
Barcelona, Barcelona, Spain
Recruiting - Vall D'Hebron Institute of Oncology
Barcelona, Barcelona, Spain
Recruiting - Next Oncology
Madrid, Spain
Recruiting
- Royal Marsden Nhs Foundation Trust
Sutton, Surrey, United Kingdom
Recruiting
- Rocky Mountain Cancer Center
Colorado Springs, Colorado, United States
Recruiting - South Florida Oncology and Hematology
Plantation, Florida, United States
Recruiting - Illinois Cancer Specialists
Arlington Heights, Illinois, United States
Recruiting - Comprehensive Urologic Care
Lake Barrington, Illinois, United States
Recruiting - First Urology
Jeffersonville, Indiana, United States
Recruiting - Marlene & Stewart Greenebaum Comprehensive Cancer Center, University of Maryland
Baltimore, Maryland, United States
Recruiting - Maryland Oncology Hematology
Silver Spring, Maryland, United States
Recruiting - Karmanos
Detroit, Michigan, United States
Recruiting - Minnesota Oncology Hematology
Minneapolis, Minnesota, United States
Recruiting - Memorial Sloane Kettering Cancer Center
New York, New York, United States
Recruiting - Levine Cancer Institute
Charlotte, North Carolina, United States
Recruiting - Midlantic Urology
Bala-Cynwyd, Pennsylvania, United States
Not, yet, recruiting - Keystone Urology Specialists
Lancaster, Pennsylvania, United States
Recruiting - Amarillo Urology Research
Amarillo, Texas, United States
Recruiting - Urology Clinics of North Texas
Dallas, Texas, United States
Recruiting - Huntsman Cancer Institute, University of Utah
Salt Lake City, Utah, United States
Recruiting - Virginia Oncology Associates
Fairfax, Virginia, United States
Recruiting - Virginia Cancer Specialists
Norfolk, Virginia, United States
Not, yet, recruiting - University of Washington, Fred Hutchinson Cancer Center
Seattle, Washington, United States
Recruiting - University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, United States
Not, yet, recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Jun 2022
- Primary completion
- 30 Jun 2027
- Completion
- 30 Apr 2028
- Last update posted
- 9 Jul 2026
- Registered enrollment
- 275
- Registry id
- NCT05413421
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.